Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001288123-17-000044)

Filing Details

Accession Number:: 0001288123-17-000044
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-12-14 16:38:26
Reporting Period:: 2017-10-09

Accepted Time:: 2017-12-14 16:38:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1098972	Agenus Inc	AGEN	Biological Products, (No Disgnostic Substances) (2836)	061562417

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1579446	Ozer Baysal	Agenus Inc. 3 Forbes Road Lexington MA 02421	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-10-09	13,080	$3.59	62,502	No	4	A	Direct
Common Stock	Disposition	2017-12-12	3,712	$3.46	58,790	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

Represents settlement of restricted shares awarded on July 1, 2015.
Represents sales of shares sold solely to cover Federal, state and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and $3.44 per share.